GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arrowhead Pharmaceuticals Inc (STU:HDP1) » Definitions » Marketable Securities

Arrowhead Pharmaceuticals (STU:HDP1) Marketable Securities : €363.78 Mil (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Arrowhead Pharmaceuticals Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Arrowhead Pharmaceuticals's Marketable Securities for the quarter that ended in Mar. 2024 was €363.78 Mil.

Arrowhead Pharmaceuticals's annual Marketable Securities increased from Sep. 2021 (€155.85 Mil) to Sep. 2022 (€271.08 Mil) and increased from Sep. 2022 (€271.08 Mil) to Sep. 2023 (€274.29 Mil).

Arrowhead Pharmaceuticals Marketable Securities Historical Data

The historical data trend for Arrowhead Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arrowhead Pharmaceuticals Marketable Securities Chart

Arrowhead Pharmaceuticals Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.51 145.95 155.85 271.08 274.29

Arrowhead Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 323.21 319.70 274.29 148.61 363.78

Arrowhead Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Arrowhead Pharmaceuticals  (STU:HDP1) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Arrowhead Pharmaceuticals Marketable Securities Related Terms

Thank you for viewing the detailed overview of Arrowhead Pharmaceuticals's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Arrowhead Pharmaceuticals (STU:HDP1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arrowhead Pharmaceuticals Inc (STU:HDP1) » Definitions » Marketable Securities
Comparable Companies
CGON ACAD ACLX SMMT MLTX APGE MRUS IDYA JANX FOLD OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
ARWR:USA
Address
177 E. Colorado Boulevard, Suite 700, Pasadena, CA, USA, 91105
Website
https://www.arrowheadpharma.com
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Arrowhead Pharmaceuticals (STU:HDP1) Headlines

No Headlines